IRCZX | NTKLX | IRCZX / NTKLX | |
Total Expense Ratio | N/A | N/A | - |
Annual Report Gross Expense Ratio | N/A | N/A | - |
Fund Existence | 9 years | 30 years | - |
Gain YTD | 0.598 | 2.741 | 22% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 0 | 1000 | - |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 1.07B | 291M | 368% |
Annual Yield % from dividends | 2.80 | 1.59 | 176% |
Returns for 1 year | 11.54 | 10.70 | 108% |
Returns for 3 years | 2.12 | 6.74 | 31% |
Returns for 5 years | 16.10 | 20.24 | 80% |
Returns for 10 years | N/A | 50.60 | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
EEMPX | 8.01 | 0.02 | +0.25% |
MFS Emerging Markets Equity Research A | |||
JFNIX | 69.38 | 0.02 | +0.03% |
Janus Henderson Global Life Sciences I | |||
IYSIX | 22.86 | -0.08 | -0.35% |
Macquarie Small Cap Growth Instl | |||
ODMCX | 11.40 | -0.06 | -0.52% |
JPMorgan SMID Cap Equity C | |||
EKGAX | 36.83 | -0.32 | -0.86% |
Allspring Special Global Small Cap A |